Immunohistochemistry Doctors Abroad — Page 5

Professor Kayihan Engin is the Director of Oncological Sciences at Medicana Bursa Hospital. He manages advanced cancer programs with expertise in tumor analysis through immunohistochemistry.

• Completed a post-doctoral radiation fellowship at Thomas Jefferson University in the USA
• Former Chairman of Radiation Oncology at Uludag University Medical College
• Specializes in gastrointestinal, breast, and lung cancer diagnostic pathways
• Conducted cancer risk research at the National Cancer Institute in Bethesda
• Managed oncological science programs at Anadolu Medical Center for 13 years

Professor Tolga Akman leads urological oncology at Medicana Bahcelievler Hospital. He uses immunohistochemistry to precisely type prostate, bladder, and kidney cancers during surgical planning.

• Professor of Medicine at Istanbul University – a top-tier medical training institution
• Specializes in radical and partial nephrectomies for kidney cancer treatment
• Performs laparoscopic urology to offer patients minimally invasive surgical options
• Expert in pediatric urology – treats complex congenital conditions like vesicoureteral reflux
• Trained at Istanbul University School of Medicine in advanced urological surgery

Dr. Cubillo Gracián heads the Medical Oncology Service at Hospital Universitario HM Sanchinarro. He uses immunohistochemistry and molecular markers to design targeted cancer treatment plans.

• Heads the Head and Neck Unit – a specialized cancer division since 2007
• Leads a liquid biopsy program – analyzes tumor genetics using blood samples
• Director of Postgraduate Research – oversees clinical studies at HM CIOCC
• Associate Professor of Oncology – teaches pathology at USP CEU university
• Co-investigator for clinical trials – researches new therapies for advanced cancer cases

Dr. Prakash Pandit is a consultant radiation oncologist at HCG Manavata Cancer Centre. He utilizes immunohistochemistry to guide precise cancer care strategies.

• Holds an MD in radiation oncology from a specialized medical program
• Expert in tomotherapy-H – a highly precise form of radiation therapy
• Performs brachytherapy – places radioactive sources inside the body to treat cancer
• Uses linear accelerator technology for targeted external beam radiation

Dr. Shruti Kate is the Head of Medical Oncology at HCG Manavata Cancer Centre. She provides expert analysis for immunohistochemistry to guide targeted cancer treatments.

• Trained at Tata Memorial Hospital – India's premier cancer treatment and research center
• Specializes in immunotherapy which uses lab tests to activate the immune system
• Solo recipient of the 2018 World Conference on Lung Cancer travel award
• Member of the American Society of Clinical Oncology and the Immuno-Oncology Society
• Expertise includes solid tumors, blood cancers, and complex pediatric oncology cases

Dr. Chaitainya Borde has handled over 30,000 PET scans at HCG Manavata Cancer Centre. He leads nuclear medicine diagnostics and specialized hormone therapy services.

• Specializes in immunohistochemistry for precise tumor identification and cancer staging
• Performs nuclear cardiology services to evaluate heart blood flow and function
• Handled treatments for over 1,000 thyroid cancer patients
• Published research papers in various peer-reviewed medical journals
• Expert in Lu-177 therapies for treating advanced prostate and neuroendocrine tumors

Dr. Sridhar P.S. is a specialist in radiotherapy who supports advanced diagnostics at HCG Manavata Cancer Centre.

• Holds a Diplomate of National Board in radiotherapy – a high medical certification in India
• Earned a Doctor of Medicine from Banaras Hindu University
• Member of the Society for Neuro-Oncology – focusing on brain and spinal cord tumors
• Collaborates on immunohistochemistry to guide targeted cancer care plans
• Active member of the Association of Radiation Oncology of India

Dr. Ali Hakan Kaya is a hematologist at Biruni University Hospital in Istanbul. He won first prize from the Blood and Bone Marrow Transplantation Association for his research. Dr. Kaya specializes in stem cell transplants and treating complex blood cancers. He works at a TEMOS-accredited university hospital equipped with a dedicated hematology-oncology department.

• Performs allogeneic bone marrow transplants from both related and unrelated donors.
• Treats leukemia, myeloma, and various types of lymphoma using CAR T-cell therapy.
• Is a member of the Turkish Apheresis Society and the Hematologic Oncology Society.
• Received multiple awards for his scientific papers on hematologic immunology and oncology.